PDCD1 and atherosclerosis: Therefore, even if PD-1−/− LDLR−/− mice present an elevated formation of atherosclerosis plaques [14], a retrospective study showed that PD-1 inhibitor, nivolumab, was associated with a favorable course for atherosclerotic lesions [15].